Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
Leblanc
M
M
D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D004926:Escherichia coli; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007710:Klebsiella Infections / Q000188:drug therapy; D007711:Klebsiella pneumoniae; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000382:microbiology; D016868:Serratia Infections / Q000188:drug therapy; D012706:Serratia marcescens
D000890:Anti-Infective Agents; D002939:Ciprofloxacin